Investigating Neurocognitive Disorders Epidemiology
Recruiting
Observational Study
Dementia
Cognitive Decline
Alzheimer Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 35 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 990 (estimated)
- Sponsor
- King Chulalongkorn Memorial Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective cohort study with the main purpose of predicting progression neurocognitive disorders in Thai population. The main predictor variables to be evaluated are plasma phosphorylated tau (p-tau) level and cognitive test scores, which will be combined using statistical/computational modeling. Additionally, it seeks to evaluate biomarkers for diagnosing disease pathologies, understan…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
1. Cognitively Healthy Individuals
INCLUSION CRITERIA
* Demonstrate normal cognitive function within the expected range on objective cognitive tests.
* Proficient in speaking and understanding Thai without the need for a translator to participate.
EXCLUSION CRITERIA
* Significant ne…
Contacts